Bank of America
NMTR

Bank of America’s 9 Meters Biopharma NMTR Stock Holding History

Bank of America’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5,733
Closed -$3.85K – 8136
2023
Q2 		$3.85K Hold
5,733
– – ﹤0.01% 7041
2023
Q1 		$7.97K Buy
5,733
+135
+2% +$255 ﹤0.01% 6973
2022
Q4 		$7.05K Buy
5,598
+309
+6% +$705 ﹤0.01% 6994
2022
Q3 		$23K Buy
5,289
+2,814
+114% +$13.9K ﹤0.01% 6987
2022
Q2 		$13K Buy
2,475
+355
+17% +$3.35K ﹤0.01% 7328
2022
Q1 		$25K Sell
2,120
-3,760
-64% -$51.3K ﹤0.01% 7441
2021
Q4 		$114K Buy
5,880
+3,668
+166% +$82.1K ﹤0.01% 6827
2021
Q3 		$57K Sell
2,212
-6,598
-75% -$155K ﹤0.01% 6988
2021
Q2 		$194K Buy
8,810
+6,614
+301% +$162K ﹤0.01% 6123
2021
Q1 		$52K Buy
+2,196
New +$67.5K ﹤0.01% 6621
2020
Q2 		– Sell
-140
Closed -$1K – 7231
2020
Q1 		$1K Buy
+140
New +$1.75K ﹤0.01% 6754
2019
Q3 		– Sell
-744
Closed -$17K – 7603
2019
Q2 		$17K Buy
744
+570
+328% +$17.1K ﹤0.01% 6612
2019
Q1 		$6K Sell
174
-383
-69% -$16.6K ﹤0.01% 6773
2018
Q4 		$25K Buy
557
+362
+186% +$26.8K ﹤0.01% 6435
2018
Q3 		$27K Sell
195
-2,933
-94% -$504K ﹤0.01% 6417
2018
Q2 		$1.47M Buy
3,128
+2,779
+796% +$1.02M ﹤0.01% 4215
2018
Q1 		$191K Buy
+349
New +$67.9K ﹤0.01% 5395
2017
Q1 		– Hold
0
– – – 7317
2016
Q4 		– Hold
0
– – – 7415

Other funds holding NMTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SIS
Strategic Investment Solutions Orland Park, Illinois $437M AUM 30.41% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $605M AUM 17.2% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
RFA
Register Financial Advisors Atlanta, Georgia $326M AUM 48.38% 1-Year Est. Return

Bank of America's NMTR Position: Q3 2023 in Review

Bank of America sold out of 9 Meters Biopharma (NMTR) in Q3 2023, closing a stake of 5,733 shares — an estimated $3.85K sold.

Bank of America first reported a position in NMTR in Q1 2018 and held it in 17 quarters. The position peaked at $1.47M in Q2 2018. 6 funds tracked by Wall St. Rank hold NMTR as of Q3 2023.

  • Bank of America reported no remaining 9 Meters Biopharma position as of Q3 2023 after selling out during the quarter.
  • Bank of America sold 5,733 9 Meters Biopharma shares in Q3 2023, an estimated $3.85K.
  • Bank of America first reported a position in 9 Meters Biopharma in Q1 2018 and held it in 17 quarters.
  • Bank of America's 9 Meters Biopharma position peaked at $1.47M in Q2 2018.
  • 6 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2023.

Based on Bank of America's 13F filing for Q3 2023, filed 14 Nov 2023.